Loading
Sentiment · FY2026 Q2
As of FY2026 Q1, the Tellvest earnings-call sentiment score for Alexandria Real Estate Equities (ARE) is 2/10.
Alexandria's Q1 2026 was marked by the unprecedented absence of any public biotech leasing and a sharp 320 bps occupancy decline to 87.7% as 657,000 square feet of known vacates materialized. FFO fell to $1.73 per share, but management reaffirmed the full-year $6.40 midpoint as development leasing momentum (394K sqft of leases and LOIs) and the advanced technology pivot at 311 Arsenal and 3000 Minuteman provided alternative demand sources. The disposition program remained on track with 80% of the $2.9 billion target pending or in process, highlighted by record $1,645/sqft pricing on the 409 Illinois Street sale, while the court defeat of NIH's 15% indirect cost limitation offered a potential catalyst for institutional demand recovery.
Scored from Alexandria Real Estate Equities’s FY2026 Q1 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $763M | +2.8% | $-0.38 | -116.6% | 21.0% | -8.2% | $274M |
| FY2025 Q1 | $743M | -1.6% | $-0.07 | -107.0% | 19.4% | -1.2% | $208M |
| FY2025 Q2 | $737M | -2.4% | $-0.64 | -356.0% | 18.7% | -14.5% | $460M |
| FY2025 Q3 | $736M | -5.1% | $-1.38 | -243.8% | 17.3% | -31.6% | $433M |
| FY2025 Q4 | $754M | -1.2% | $-6.35 | -1571.1% | -213.6% | -143.4% | $312M |
| FY2026 Q1 | $671M | -9.7% | $2.10 | +3188.2% | 15.9% | 59.4% | $197M |
| FY2026 Q2 | $796M | +8.0% | $0.07 | +110.3% | 3.1% | 1.5% | $-66M |